WFC Q3 EPS Beats on Wealth Strength; BUY Thesis Intact

What happened

Wells Fargo reported Q3 2026 EPS of $1.87, exceeding consensus estimates by $0.02 and rising 13% year-over-year, while net income increased 6% to $5.95 billion. The beat was attributed to strength in wealth management, consistent with the firm's diversified fee income that had already been offsetting net interest income pressure in prior quarters. This update aligns with the DeepValue BUY thesis, which highlighted improving earnings mix and fee resilience, though the modest beat and 6% net income growth suggest limited upside from this quarter alone. Key watch items from the master report remain open: NII/NIM stabilization, credit normalization (including CRE), and capital rule outcomes; none are addressed in this short earnings snippet. Therefore, while the report is a positive incremental data point, it does not materially alter the investment stance, and the BUY rating stands pending further details on credit quality and net interest margin trajectory.

Implication

The modest earnings beat and wealth management strength validate the core thesis that fee income can counterbalance NII headwinds, but the 2-cent beat is not sufficient to re-rate the stock on its own. Investors should await the full 10-Q and earnings call for details on net interest margin, deposit costs, and credit provisions, as these will determine whether the NII compression is stabilizing. The continued absence of adverse credit news is positive, but with nonperforming assets already at $8.0 billion, any uptick in commercial real estate delinquencies could pressure the stock. Capital return and regulatory developments, particularly the SCB update, remain pivotal; confirmation of the expected ~2.5% SCB would support multiple expansion, while a higher requirement would temper upside. Overall, the risk/reward still favors holding the BUY rating, with the stock trading at ~1.6x P/B versus top-tier peers, but investors should not extrapolate this single quarter's modest beat into a trend without further evidence.

Thesis delta

The thesis remains unchanged: BUY. The Q3 earnings beat is consistent with the existing expectation of fee income offsetting NII pressure, though the magnitude is small. No update on credit or capital rules, so the key uncertainties remain unchanged.